Cargando…

COVID-19: a cause of recurrent Graves’ hyperthyroidism?

Detalles Bibliográficos
Autores principales:	Jiménez-Blanco, S., Pla-Peris, B., Marazuela, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538276/ https://www.ncbi.nlm.nih.gov/pubmed/33025554 http://dx.doi.org/10.1007/s40618-020-01440-0

Ejemplares similares

Pancytopenia with cellular bone marrow related to Graves’ hyperthyroidism
por: Raina, Sujeet, et al.
Publicado: (2012)

Tozinameran: Recurrence of hyperthyroidism secondary to Graves' disease: case report
Publicado: (2021)

Prediction for recurrence following antithyroid drug therapy for Graves’ hyperthyroidism
por: Weng, Huan, et al.
Publicado: (2023)

Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic
por: Bartalena, L., et al.
Publicado: (2020)

A Clinical Debate: What Is the Therapeutic Choice for Recurrent Graves’ Hyperthyroidism?
por: Abdi, Hengameh, et al.
Publicado: (2020)

R-CHOP-Associated Graves' Hyperthyroidism
por: Mora, Natalie, et al.
Publicado: (2019)

Graves’ hyperthyroidism in pregnancy: a clinical review
por: Nguyen, Caroline T., et al.
Publicado: (2018)

New Therapeutic Horizons for Graves’ Hyperthyroidism
por: Lane, Laura C, et al.
Publicado: (2020)

The importance of an individual approach to Graves’ hyperthyroidism
por: Bednarczuk, Tomasz
Publicado: (2015)

Alternating hyperthyroidism and hypothyroidism in Graves’ disease
por: Wong, Mimi, et al.
Publicado: (2018)

Toward Ultimate Care for Graves’ Hyperthyroidism
por: Azizi, Fereidoun, et al.
Publicado: (2019)

The Grave Hematologic and Hepatic Effects of Hyperthyroidism
por: Ahmad, Sara Miriam, et al.
Publicado: (2021)

Severe and treatment-resistant hypocalcemia in patient with bilateral COVID-19 pneumonia()
por: Pla, Begoña, et al.
Publicado: (2021)

Graves’ disease and Graves’ orbitopathy following COVID-19
por: Lanzolla, G., et al.
Publicado: (2021)

The Incidence of Graves’ hyperthyroidism before and After COVID-19 mRNA Vaccination
por: Endo, Mayumi, et al.
Publicado: (2023)

Current and emerging treatment options for Graves’ hyperthyroidism
por: Abraham, Prakash, et al.
Publicado: (2010)

Hyperthyroidism and Graves’ disease: Is an ultrasound examination needed?
por: Varadhan, Lakshminarayanan, et al.
Publicado: (2016)

The Influence of Prior Hyperthyroidism on Euthyroid Graves' Ophthalmopathy
por: Termote, Karolien, et al.
Publicado: (2014)

Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
por: Lanzolla, Giulia, et al.
Publicado: (2021)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
por: Le Moli, Rosario, et al.
Publicado: (2020)

A patient-specific treatment model for Graves’ hyperthyroidism
por: Pandiyan, Balamurugan, et al.
Publicado: (2018)

Urticarial vasculitis in a young woman with Graves hyperthyroidism
por: Hung, Yi-Teng, et al.
Publicado: (2022)

Iatrogenic Hyperthyroidism With Recurrent Functioning Thyroid Tissue 40 Years After Thyroidectomy for Graves’ Disease
por: Penquite, Sara Ashlyn, et al.
Publicado: (2021)

Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism
por: Abbara, Ali, et al.
Publicado: (2020)

Radioiodine Thyroid Ablation in Graves’ Hyperthyroidism: Merits and Pitfalls
por: Nwatsock, J. F., et al.
Publicado: (2012)

Unilateral gynecomastia as an initial presentation of hyperthyroid Graves’ disease
por: Sakulterdkiat, Titipatima, et al.
Publicado: (2021)

AZD-1222: Aggravation of Graves hyperthyroidism: case report
Publicado: (2022)

Hyperthyroidism Due to Graves Disease After Radiofrequency Ablation
por: McAninch, Elizabeth A, et al.
Publicado: (2023)

Clinical diagnosis of Graves’ or non-Graves’ hyperthyroidism compared to TSH receptor antibody test
por: Bell, Lauren, et al.
Publicado: (2018)

A Grave Case of COVID-19: SARS-CoV-2 Induced Autoimmune Hyperthyroidism
por: Matos, Moises, et al.
Publicado: (2021)

Benefits of Long-Term Continuation of Low-Dose Methimazole Therapy in the Prevention of Recurrent Hyperthyroidism in Graves' Hyperthyroid Patients: A Randomized Prospective Controlled Study
por: Lertwattanarak, Raweewan, et al.
Publicado: (2022)

Unilateral Graves’ Disease in a Bilobar Thyroid Gland: A Very Unusual Cause of Hyperthyroidism
por: Alaybaa, Khaled, et al.
Publicado: (2023)

THU665 Unilateral Graves’ Disease In A Bilobar Thyroid Gland: Unusual Cause Of Hyperthyroidism
por: Hamid Alaybaa, Khaled, et al.
Publicado: (2023)

Predictors of Atrial Fibrillation Recurrence in Hyperthyroid and Euthyroid Patients
por: Cerit, Levent
Publicado: (2016)

Simultaneous induction of Graves’ hyperthyroidism and Graves’ ophthalmopathy by TSHR genetic immunization in BALB/c mice
por: Xia, Nan, et al.
Publicado: (2017)

Thyroid Function after Subtotal Thyroidectomy in Patients with Graves' Hyperthyroidism
por: Limonard, E. J., et al.
Publicado: (2012)

FRI462 Incidence Of Graves Hyperthyroidism Before And After The Implementation Of COVID-19 mRNA Vaccination
por: Oliveira Pinto, Jessica, et al.
Publicado: (2023)

Effects of treatment modalities for Graves’ hyperthyroidism on Graves’ orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement
por: Bartalena, L., et al.
Publicado: (2015)

A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism
por: Doi, Suhail AR, et al.
Publicado: (2001)

Use of Lithium in Hyperthyroidism Secondary to Graves’ Disease: A Case Report
por: Sharma, Pranjali P.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_59n36r1als47d8f2aav5o367be